HiVAC
Showing 1 - 10 of 10
HIV Trial in Seattle (HIVAC-1e, gp160 Vaccine (MicroGeneSys))
Completed
- HIV Infections
- HIVAC-1e
- gp160 Vaccine (MicroGeneSys)
-
Seattle, WashingtonChildren's Hospital & Medical Center / Seattle ACTU
Oct 26, 2021
HIV Trial in Pittsburgh (rgp120/HIV-1 SF-2, Env 2-3, HIVAC-1e)
Completed
- HIV Infections
- rgp120/HIV-1 SF-2
- +3 more
-
Pittsburgh, PennsylvaniaJHU AVEG
Oct 27, 2021
HIV Trial in Nashville, Seattle (HIVAC-1e, gp160 Vaccine (MicroGeneSys))
Completed
- HIV Infections
- HIVAC-1e
- gp160 Vaccine (MicroGeneSys)
-
Nashville, Tennessee
- +1 more
Oct 26, 2021
HIV Trial in Rochester, Seattle (gp160 Vaccine (Immuno-AG), rgp120/HIV-1IIIB, rgp120/HIV-1MN)
Completed
- HIV Infections
- gp160 Vaccine (Immuno-AG)
- +4 more
-
Rochester, New York
- +1 more
Oct 28, 2021
HIV Trial in Rochester (HIVAC-1e, gp160 Vaccine (MicroGeneSys))
Completed
- HIV Infections
- HIVAC-1e
- gp160 Vaccine (MicroGeneSys)
-
Rochester, New YorkUniv. of Rochester AVEG
Oct 26, 2021
HIV, HIV Seronegativity Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))
Completed
- HIV Infections
- HIV Seronegativity
- gp160 Vaccine (Immuno-AG)
-
Saint Louis, Missouri
- +1 more
Oct 28, 2021
Healthy Trial (763SIP8/MPLA-5 vaccine)
Not yet recruiting
- Healthy
- 763SIP8/MPLA-5 vaccine
- (no location specified)
Mar 15, 2023
ALL, Burkitt's Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (Rapamycin + high dose etoposide and cytarabine)
Terminated
- ALL
- +3 more
- Rapamycin + high dose etoposide and cytarabine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Abramson Cancer Center
Apr 15, 2020
HIV Trial in Greater London (GTU®-multiHIV B clade)
Unknown status
- HIV
- GTU®-multiHIV B clade
-
Greater London, United KingdomImperial College London
Feb 27, 2014
HIV Trial in Wallingford (Smallpox Vaccine, HIVAC-1e, gp160 Vaccine (MicroGeneSys))
Completed
- HIV Infections
- Smallpox Vaccine
- +2 more
-
Wallingford, ConnecticutBristol - Myers Squibb Co
Sep 24, 2007